Kenji Sugawara

Kenji Sugawara

Auto-generated profile, based on publicly available information

Kenji Sugawara

Division of Diabetes and Endocrinology, Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2020 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Closed access
PDF file
JIJun Ito
Jun Ito
MNMunenobu Nogami
Munenobu Nogami
YMYasuko Morita
Yasuko Morita
KSKazuhiko Sakaguchi
Kazuhiko Sakaguchi
HKHisako Komada
Hisako Komada
WOWataru Ogawa
Wataru Ogawa

23 December 2019 in Journal of Diabetes Investigation
Verified
Journal Article
Open access
PDF file
KSKenji Sugawara
Kenji Sugawara
YOYuko Okada
Yuko Okada
YHYushi Hirota
Yushi Hirota
KSKazuhiko Sakaguchi
Kazuhiko Sakaguchi
WOWataru Ogawa
Wataru Ogawa
Aims/Introduction: Metformin therapy has been associated with vitamin B12 (VB12) deficiency, but information regarding this adverse effect in Asian populations is limited. We have now examined the relationship between metformin use and VB12 status in individuals with type 2 diabetes mellitus in Japan.Materials and Methods: This cross‐sectional study was carried out with type 2 diabetes mellitus patients treated (Met group, n = 122) or not treated (control group, n = 63) with metformin. The primary end‐point was the difference in the serum concentration of homocysteine, a marker of VB12 activity, between the two groups. The serum concentrations of VB12, blood hemoglobin level and mean corpuscular volume were also compared between the groups. Subset analysis was carried out with individuals aged ≥70 years. The potential correlation between the daily dose or duration of metformin treatment and the other measured parameters was also examined.Results: The level of homocysteine, as well as the VB12 level, hemoglobin concentration and mean corpuscular volume, did not differ significantly between the control and treated with metformin groups. The level of homocysteine was positively and that of VB12 negatively correlated with the daily dose of metformin. Among elderly individuals, the hemoglobin level was significantly lower in the treated with metformin group than in the control group, although the mean corpuscular volume was similar in the two groups.Conclusions: The risk of VB12 deficiency during metformin treatment appears to be low in Japanese type 2 diabetes mellitus patients. However, high doses of metformin might result in a moderate decrease in the circulating VB12 level, as well as in anemia in elderly individuals.

1 December 1997 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
STSatoshi Tanno
Satoshi Tanno
TOTakeshi Obara
Takeshi Obara
RSRyushi Shudo
Ryushi Shudo
TFTsuneshi Fujii
Tsuneshi Fujii
KSKenji Sugawara
Kenji Sugawara
YKYutaka Kohgo
Yutaka Kohgo

15 February 2021 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Open access
PDF file
JIJun Ito
Jun Ito
MNMunenobu Nogami
Munenobu Nogami
YMYasuko Morita
Yasuko Morita
KSKazuhiko Sakaguchi
Kazuhiko Sakaguchi
HKHisako Komada
Hisako Komada
WOWataru Ogawa
Wataru Ogawa
The cover image is based on the Original Article Dose‐dependent accumulation of glucose in the intestinal wall and lumen induced by metformin as revealed by 18F‐labelled fluorodeoxyglucose positron e...